Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Xiao-Ling Ni"'
Autor:
Bo-Hao Zheng, Cheng Zhang, Wen-Ze Wan, Wen-Tao Sun, Xi Cheng, Xiao-Jian Ni, Xiao-Ling Ni, Tao Suo, Han Liu, Sheng Shen, Hou-Bao Liu
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background In this study, we aimed at elucidating the postoperative survival and prognostic factors in patients with biliary neuroendocrine neoplasm (NEN). Methods Cases of biliary system NEN and adenocarcinoma from 1975 to 2016 were extract
Externí odkaz:
https://doaj.org/article/977db70e4eb348f18a2ac199bc789674
Autor:
Sheng Shen, Ji‐Wen Wang, Bo‐Hao Zheng, Xiao‐Jian Ni, Zhi‐Hui Gao, De‐Xiang Zhang, Ping‐Xiang Lu, Xiao‐Ling Ni, Tao Suo, Hou‐Bao Liu, Han Liu
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 2, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/bbe6aeea2c50430c836614f40c410086
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Objective To explore the long-term efficacy and safety of the first single dose of rituximab in children with steroid-dependent minimal-change nephrotic syndrome (SD-MCNS) over a two-year period after infusion.Methods A 2-year retrospective observati
Externí odkaz:
https://doaj.org/article/d93d14e96a5343988ca2725e6b0f3f0f
Autor:
Jing-Bo Wu, Bo Yang, Ling Lin Yang, Jing Liu, ShaoZhi Fu, Long Xia Chen, Yue Chen, Min Wu, Shan Xu, Heng Zhang, Xiao Ling Ni
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1501-1512 (2017)
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1501-1512 (2017)
Gefitinib (GEF) is the first epidermal growth factor receptor (EGFR)-targeting agent launched as an anticancer drug. It is an accepted opinion that modifying GEF strong hydrophobicity and poor bioavailability would not only enhance its antitumor effe
Autor:
Heng Zhang, Long Xia Chen, Jing Liu, Ling Lin Yang, ShaoZhi Fu, Min Wu, Xiao Ling Ni, Jingbo Wu, Shan Xu
Publikováno v:
International Journal of Nanomedicine
Long Xia Chen,* Xiao Ling Ni,* Heng Zhang, Min Wu, Jing Liu, Shan Xu, Ling Lin Yang, Shao Zhi Fu, Jingbo Wu Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China *These authors contribut
Autor:
Xiao Ling Ni, Dan Song Wang, Wen Hui Lou, Wen Chuan Wu, Tian Tao Kuang, Xue Feng Xu, Da Yong Jin
Publikováno v:
Journal of digestive diseases. 10(1)
OBJECTIVE: To investigate the relationship between pancreatic cancer (PC) and diabetes mellitus. METHODS: All PC patients diagnosed and treated at Zhongshan hospital from January 1991 to December 2007 were retrospectively analyzed. During this period
Publikováno v:
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 11(6)
To investigate the prevention and treatment for postsurgical gastroparesis syndrome (PGS) after pancreaticoduodenectomy.The data of 18 PGS cases after pancreaticoduodenectomy were analyzed.PGS of these 18 patients occurred within 4-10 days after oper
Autor:
Wen-hui, Lou, Dan-song, Wang, Yuan, Ji, Xue-feng, Xu, Tian-tao, Kuang, Xiao-ling, Ni, Wen-chuan, Wu, Da-yong, Jin
Publikováno v:
Zhonghua yi xue za zhi. 86(14)
To explore the diagnosis, clinical manifestation, treatment, and prognosis of intraductal papillary mucinous neoplasms (IPMNs) of pancreas.The clinical data of 38 patients with IPMNs, 23 males and 15 females, aged 64.1 +/- 10.7 (41 - 81), were analyz
Autor:
Yong Liu, Wei-Guo Liu, Da-Bin Lin, Xiao-Ling Niu, Shun Zhou, Jin Zhang, Shao-Bo Ge, Ye-Chuan Zhu, Xiao Meng, Zhi-Li Chen
Publikováno v:
Nanomaterials, Vol 12, Iss 4, p 588 (2022)
The films of vinylidene fluoride and trifluoroethylene (P(VDF-TrFE)) are widely used in piezoelectric tactile sensors, vibration energy harvesters, optical frequency conversion materials and organic photo-voltaic devices because of high electroactive
Externí odkaz:
https://doaj.org/article/146047e4ebe34d42969b08c2a8cc4671
Publikováno v:
Biological Research, Vol 51, Iss 1, Pp 1-8 (2018)
Abstract Background Neurokinin1 (NK1) receptor has played a vital role in the development of tumor. However, NKP608 as a NK1 receptor antagonist whether has the effect of the resistance of colorectal cancer is still unclear. Thereby, in this study, w
Externí odkaz:
https://doaj.org/article/81b2cc1377e4425e804c50983221ccd2